Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov ID: NCT04751487

Public ClinicalTrials.gov record NCT04751487. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 6:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of SAR440340/ REGN3500/ Itepekimab (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary Objective: Primary population (former smokers cohort): \- Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in former smokers with moderate-to-severe COPD Secondary Objectives: Primary population (former smokers cohort): * Evaluate the efficacy of itepekimab compared with placebo on pulmonary function in former smokers with moderate-to-severe COPD * Evaluate the efficacy of itepekimab compared with placebo on occurrence of acute exacerbation of COPD (AECOPD) in former smokers with moderate-to-severe COPD * Evaluate the efficacy of itepekimab compared with placebo on severe AECOPD in former smokers with moderate-to-severe COPD * Evaluate the efficacy of itepekimab compared with placebo on corticosteroid-treated AECOPD in former smokers with moderate-to-severe COPD * Evaluate the efficacy of itepekimab compared with placebo on respiratory symptoms in former smokers with moderate-to-severe COPD * Evaluate the efficacy of itepekimab compared with placebo on Forced Expiratory Volume in 1 second (FEV1) slope in former smokers with moderate-to-severe COPD * Evaluate the efficacy of itepekimab compared with placebo on health-related quality of life (HRQoL) as assessed by St. George's Respiratory Questionnaire (SGRQ) in former smokers with moderate-to-severe COPD * Evaluate the safety and tolerability of itepekimab in former smokers with moderate-to-severe COPD * Evaluate the pharmacokinetic (PK) profile of itepekimab in former smokers with moderate-to-severe COPD * Evaluate immunogenicity to itepekimab in former smokers with moderate-to-severe COPD Secondary population (current smokers cohort) * Estimate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate or severe COPD exacerbations in current smokers with moderate-to-severe COPD * Estimate the efficacy of itepekimab compared with placebo on pulmonary function in current smokers with moderate-to-severe COPD * Estimate the safety and tolerability of itepekimab in current smokers with moderate-to-severe COPD * Estimate the PK profile of itepekimab in current smokers with moderate to severe COPD * Estimate immunogenicity to itepekimab in current smokers with moderate-to-severe COPD

Study identification

NCT ID
NCT04751487
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
1,234 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 12, 2021 (Actual)
Primary completion
Apr 21, 2025 (Actual)
Completion
Aug 28, 2025 (Actual)
Last update posted
Oct 9, 2026

2021 – 2025

United States locations

U.S. sites
59
U.S. states
21
U.S. cities
52
Facility City State ZIP Site status
Synexus Phoenix Central (Central Phoenix Medical Clinic)- Site Number : 8400333 Phoenix Arizona 85020 —
UCSF Fresno - Site Number : 8400030 Fresno California 93701 —
Palmtree Clinical Research Site Number : 8400184 Palm Springs California 92262 —
Allianz Research Institute Colorado Site Number : 8400061 Denver Colorado 80219 —
Helix Biomedics, LLC - Site Number : 8400049 Boynton Beach Florida 33435 —
Innovative Research of West Florida, Inc- Site Number : 8400041 Clearwater Florida 33756 —
Beautiful Minds Clinical Research Center Site Number : 8400352 Cutler Bay Florida 33157 —
Omega Research - Site Number : 8400031 DeBary Florida 32713 —
Sciences Connections, LLC Site Number : 8400045 Doral Florida 33178 —
North Florida/South Georgia Veterans Health System Site Number : 8400176 Gainesville Florida 32608 —
Finlay Medical Research- Site Number : 8400011 Greenacres City Florida 33467 —
Direct Helpers Medical Center Inc- Site Number : 8400065 Hialeah Florida 33012 —
Multi-Specialty Research Associates, Inc- Site Number : 8400044 Lake City Florida 32055 —
Advanced Pulmonary Research Institute Site Number : 8400018 Loxahatchee Groves Florida 33470 —
Columbus Clinical Services- Site Number : 8400054 Miami Florida 33125 —
Finlay Medical Research Site Number : 8400007 Miami Florida 33126 —
MCR Research Site Number : 8400425 Miami Florida 33126 —
Y and L Advance Health Care, Inc D/B/A Elite Clinical Res- Site Number : 8400009 Miami Florida 33144 —
My Community Research Center Site Number : 8400060 Miami Florida 33155 —
Phoenix Medical Research- Site Number : 8400019 Miami Florida 33165 —
Renstar Medical Research- Site Number : 8400015 Ocala Florida 34470 —
Central Florida Pulmonary Group, PA- Site Number : 8400192 Orlando Florida 32803 —
Oviedo Medical Research Site Number : 8400026 Oviedo Florida 32765 —
Innovation Medical Research Center- Site Number : 8400067 Palmetto Bay Florida 33157 —
Pines Care Research Center LLC- Site Number : 8400056 Pembroke Pines Florida 33025 —
Sarasota Memorial Health Care System Clinical ResearchCenter- Site Number : 8400178 Sarasota Florida 34239 —
Genesis Clinical Research, LLC Site Number : 8400182 Tampa Florida 33603 —
Clinical Research of West Florida, Inc- Site Number : 8400008 Tampa Florida 33606 —
Medster Research, LLC Site Number : 8400051 Valdosta Georgia 31605 —
North Georgia Clinical Research Site Number : 8400013 Woodstock Georgia 30189 —
Care Access Fairview Heights Site Number : 8400033 Fairview Heights Illinois 62208 —
Captain James A. Lovell Federal Health Care Center Site Number : 8400032 North Chicago Illinois 60064 —
Illinois Lung Institute- Site Number : 8400024 Peoria Illinois 61605 —
The Iowa Clinic Site Number : 8400034 West Des Moines Iowa 50266 —
Cotton O'Neil Garfield- Site Number : 8400063 Topeka Kansas 66606 —
Pulmonary & Critical Care Site Number : 8400047 Shreveport Louisiana 71105 —
Johns Hopkins Asthma and Allergy Center- Site Number : 8400055 Baltimore Maryland 21224 —
Care Access Site Number : 8400276 Boston Massachusetts 02110 —
Care Access Site Number : 8400281 Boston Massachusetts 02110 —
Revive Research Institute Site Number : 8400186 Lathrup Village Michigan 48076 —
Washington University School of Medicine- Site Number : 8400035 St Louis Missouri 63110 —
Smart Medical Research Site Number : 8400191 Brooklyn New York 11230 —
VA Western New York Healthcare System Site Number : 8400050 Buffalo New York 14215 —
New York - Presbyterian Queens- Site Number : 8400028 Flushing New York 11355 —
Schenectady Pulmonary and Critical Care Associates- Site Number : 8400029 Schenectady New York 12308 —
Advanced Respiratory and Sleep Medicine- Site Number : 8400022 Huntersville North Carolina 28078 —
University of Cincinnati- Site Number : 8400042 Cincinnati Ohio 45267 —
Toledo Institute of Clinical Research- Site Number : 8400014 Toledo Ohio 43617 —
St. Luke's University Health Network- Site Number : 8400187 Bethlehem Pennsylvania 18015 —
Temple University Hospital Site Number : 8400062 Philadelphia Pennsylvania 19140-5103 —
Allegheny Health Network- Site Number : 8400058 Pittsburgh Pennsylvania 15212 —
Lowcountry Lung & Critical Care- Site Number : 8400175 Charleston South Carolina 29406 —
Medtrial, LLC Site Number : 8400048 Columbia South Carolina 29204 —
TTS Research- Site Number : 8400012 Boerne Texas 78006 —
United Memorial Medical Center (UMMC)- Site Number : 8400193 Houston Texas 77091 —
Radiance Clinical Research- Site Number : 8400037 Lampasas Texas 76550-1820 —
Sun Research Institute - Site Number : 8400183 San Antonio Texas 78215 —
AES Salt Lake City- Site Number : 8400332 Murray Utah 84123 —
The Rheumatology and Pulmonary Clinic- Site Number : 8400053 Beckley West Virginia 25801 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 179 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04751487, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 9, 2026 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04751487 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →